אודות פרק זה

אנגלית
ארצות הברית

תעתיק 🔗

חיפוש פרקים ישנים

חפש פרקים קודמים של ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research.

פרקים אחרים בפודקאסט הזה

ecent advancements in echocardiography since ACC.25 highlight a shift toward greater precision, efficiency, and consistency in cardiac imaging. Standardized echo reporting is now recognized as a key marker of quality care, improving communication and supporting more reliable clinical decisions, wh‮…
Nonobstructive hypertrophic cardiomyopathy (HCM) represents one of the greatest areas of unmet need in HCM management. A key question is identifying the primary driver of symptoms in these patients, as many experience significant functional limitations despite the absence of left ventricular outfl‮…
The VESALIUS-CV trial demonstrated that the PCSK9 inhibitor evolocumab significantly reduced the risk of a first major cardiovascular event in patients with diabetes who had no known significant atherosclerosis. These findings challenge current clinical practice, where PCSK9 inhibitors are typical‮…
Randomized trials in stable ischemic heart disease (SIHD) show revascularization does not reduce death or myocardial infarction versus guideline-directed medical therapy, with benefit limited to symptom relief. This likely reflects lesion–ischemia mismatch, unclear ischemia origin, effective moder‮…
The "Food is Medicine" approach is central to cardiovascular disease (CVD) prevention because diet directly shapes key risk factors, making nutrition a powerful, modifiable intervention. Medically tailored meals (MTMs) are fully prepared, condition-specific meals prescribed to meet the clinical ne‮…
הצהרה: הפודקאסט והגרפיקה המוטבעים בדף זה הם מ-American College of Cardiology, שהוא רכושו של בעליו ואינו קשור או מאושר על ידי Listen Notes, Inc.